RT Conference Proceedings
T1 ABATACEPT IN MONOTHERAPY OR IN COMBINATION WITH CONVENTIONAL DISEASE-MODIFYING DRUGS: TREATMENT PERSISTENCE IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS.
A1 Munoz Reinoso, P.
A1 Garcia Hernandez, I.
A1 Hernandez-Cruz, B.
A1 Perez Venegas, J. J.
PB Bmj publishing group
SN 0003-4967
YR 2022
FD 2022-06-01
LK http://hdl.handle.net/10668/20120
UL http://hdl.handle.net/10668/20120
LA en
DS RISalud
RD Apr 16, 2025